IP Library Granted Patent US 10,842,985
Granted Patent B2
US 10,842,985 · App. 15/216,307 · Granted Nov 24, 2020

Needleless connector and access port disinfection cleaner and antimicrobial protection cap

Inventor: Jonathan Karl Burkholz (Salt Lake City, UT)
Assignee: Becton, Dickinson and Company
A61M39/162A61M5/001A61M39/16A61M39/20A61M5/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,842,985
App. No.
15/216,307
Granted
Nov 24, 2020
Kind
B2
Abstract

A protective cap having a first cap and a second cap that are removably coupled together for use in short-term and long-term antimicrobial treatment of needleless connectors and access ports of an infusion system. The instant invention further provides a protective cap having a first cap and a second cap that each coupled to a different surface of a component of an infusion system, such as a syringe. The instant invention further provides a strip containing a plurality of disposable protective caps.

Claims (18)

1. A device for antiseptically maintaining a patient fluid line access valve, the device comprising:

a first cap comprising a distal end and a proximal end, wherein the distal end of the first cap comprises a first opening having a first pad disposed therein, and the proximal end comprises a post having a solid cross-section and extending outwardly from the proximal end, the solid cross-section comprising a coupling feature; and

a second cap comprising a distal end and a proximal end, wherein the distal end of the second cap comprises a second receptacle having a second pad disposed therein, wherein the second receptacle comprises a compatible coupling feature in fluid communication with the second pad and configured to receive the coupling feature on the solid cross-section of the post of the first cap to form a fluid tight seal.

2. The device of claim 1 , wherein the first cap comprises a removable lid that covers the first opening.

3. The device of claim 2 , wherein the removable lid comprises at least one of a foil lidding material and a polymer lidding material.

4. The device of claim 1 , wherein the first opening is configured to receive an access portion of a patient fluid line access valve.

5. The device of claim 4 , wherein the first opening includes a set of threads that is configured to receive a compatible set of threads on the access portion of the patient fluid line access valve.

6. The device of claim 1 , further comprising a syringe having a first end comprising a spout and a second end comprising a base of a plunger, wherein the base of the plunger includes a circular groove that receives the distal end of the second cap to thereby couple the second cap to the plunger.

7. The device of claim 1 , further comprising a first antimicrobial solution applied to the first pad and a second antimicrobial solution applied to the second pad.

8. The device of claim 7 , wherein the first antimicrobial solution comprises a wet solution selected from at least one of a first antimicrobial agent from approximately 0.01% to approximately 10.0% (v/v), and an alcohol from approximately 50% to approximately 99.99% (v/v), wherein the second antimicrobial solution comprises a dry antimicrobial coating comprising a second antimicrobial agent.

9. The device of claim 8 , wherein the first and second antimicrobial agents are selected from the group consisting of chlorhexidine acetate, chlorhexidine gluconate, PVP-I, Triclosan, PCMX, BEC, BAC, antibiotic, Octinidine, and suitable salts thereof.

10. The device of claim 7 , wherein the first antimicrobial solution comprises a wet, water-based solution, comprising:

a first antimicrobial agent from approximately 0.01% to approximately 10.0% (v/v);

an alcohol solvent from approximately 1% to approximately 10% (v/v); and

water from approximately 90% to approximately 99% (v/v); and

wherein the second antimicrobial solution comprises a dry antimicrobial coating comprising a second antimicrobial agent.

11. The device of claim 10 , wherein the first and second antimicrobial agents are selected from the group consisting of chlorhexidine acetate, chlorhexidine gluconate, PVP-I, Triclosan, PCMX, BEC, BAC, antibiotic, Octinidine, and suitable salts thereof.

12. The device of claim 1 , wherein the first pad comprises a central, cylindrical cutout configured to compress to provide a central cavity in response to a device being inserted into the first opening, wherein the central cylindrical cutout does not provide the central cavity when the first pad is uncompressed.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2016
From: BURKHOLZ, JONATHAN KARL
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 039270/0431 →
Continuity (2)
Continuation 13766540 · Feb 13, 2013
Related Publication 20160325089A1 · Nov 10, 2016